In this study, we found that LJZD effectively regulated the amounts of CD4+CD25+Foxp3+ TReg cells, inflammatory cytokines, and immunoglobulins, which suggested that LJZD could improve the peripheral immunologic process, increase peripheral tolerance to allergens, and inhibit Th2 inflammation in the development of asthma. The gene discussed is CD4; the disease is asthma.